New research from the University of Oregon breaks down how chromium converts from a benign form in rocks and soil to a carcinogenic one in the presence of extreme heat during wildfires.

An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases. This prospective, multicenter cancer clinical trial, called FEATURE (EA1183) validated FDG-PET/CT as an improved method for predicting treatment benefits in hormone receptor-positive (HR+) metastatic breast cancer that has spread primarily or exclusively to the bones. These patients make up a large portion of individuals who are living with advanced breast cancer—yet are routinely excluded from clinical trials that rely on standard imaging-based assessments (i.e., RECIST 1.1). The study demonstrated that metabolic changes assessed by FDG-PET/CT accurately predicted progression-free survival as early as 12 weeks after treatment initiation. This trial represents a major advance in cancer imaging.

Roundworms recently discovered in Great Salt Lake are new to science. A new study by University of Utah biologists characterizes D. woaabi, the first of two nematode species collected from the lake's microbialites